Clinical Trial Update: EAP_GS010_single Patient

View source ↗

Summary

The expanded-access program for GS010 in Leber hereditary optic neuropathy is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Drugs mentioned

• GS010 (lenadogene nolparvovec)

Snippet

Sponsor: GenSight Biologics | Conditions: Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber) | Status: NO_LONGER_AVAILABLE